Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01712451 · ClinicalTrials.gov registry record · Phase 2
Dose-ranging Study
A Phase 2 study, sponsored by Neothetics.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT01712451 is a Phase 2 study that has completed, run by Neothetics. The registered enrollment target is 200 participants.
The verdict
NCT01712451, a Phase 2 study, has completed, sponsored by Neothetics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
Dose ranging study
Interventions
- DRUG Placebo
- DRUG salmeterol xinafoate, fluticasone propionate
- DRUG salmeterol xinafoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01712451
The ClinicalTrials.gov registry entry for NCT01712451 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neothetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01712451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01712451 about?
NCT01712451 is a clinical study titled "Dose-ranging Study". Dose ranging study
What is the current status of trial NCT01712451?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2011-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01712451?
The interventions under investigation include: Placebo (DRUG), salmeterol xinafoate, fluticasone propionate (DRUG), salmeterol xinafoate (DRUG).
Who is sponsoring clinical trial NCT01712451?
This trial is sponsored by Neothetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.